Clinical Trial Update: A Phase II/III Randomized Double-Blind Multicenter Study Comparing UC-MSC-Derived Secretome and Sodium Hyaluronate in Patients With Knee Osteoarthritis [Phase 2, Phase 3]

View source ↗

Summary

A Phase II/III randomized, double-blind multicenter trial comparing UC-MSC-derived secretome with sodium hyaluronate in knee osteoarthritis, currently not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Sodium Hyaluronate (sodium hyaluronate)
• UC-MSC-Derived Secretome (umbilical cord mesenchymal stem cell-derived secretome)

Snippet

Sponsor: Universitas Sriwijaya | Conditions: Knee Osteoarthritis (Knee OA) | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING